Improved survival in intensive care unit in severe COVID-19 associated with amantadine use - retrospective study
Objectives: Possible immunomodulatory effect of amantadine in patients treated in intensive care unit (ICU), mostly among patients with brain injuries or vascular diseases was observed in several studies. The potential antiviral effect of amantadine against SARS-CoV-2 was discarded in clinical trial...
Main Authors: | Daniel Chober, Zenon Czajkowski, Bogusz Aksak-Wąs, Katarzyna Dalewska-Kucharczyk, Katarzyna Hołubczak, Sylwia Karasińska-Milchert, Mateusz Jaremko, Miłosz Skowron, Malwina Karasińska-Cieślak, Miłosz Parczewski |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-11-01
|
Series: | International Journal of Infectious Diseases |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1201971222005252 |
Similar Items
-
Antiglycoxidative properties of amantadine – a systematic review and comprehensive in vitro study
by: Miłosz Nesterowicz, et al.
Published: (2023-12-01) -
"Efficacy of interferon and Amantadin for treatment of hepatitis in major thalasemia at Children’s Medical Center, Tehran "
by: Fallahi GHI, et al.
Published: (2007-04-01) -
A Case Report of Severe Delirium after Amantadine Withdrawal
by: Franz Marxreiter, et al.
Published: (2017-03-01) -
Amantadine extended-release capsules for levodopa-induced dyskinesia in patients with Parkinson's disease
by: Sharma VD, et al.
Published: (2018-04-01) -
Effectiveness of Tocilizumab in Patients with Severe or Critical Lung Involvement in COVID-19: A Retrospective Study
by: Daniel Chober, et al.
Published: (2022-04-01)